Avoro Capital Advisors LLC
Top Portfolio Positions
30 positions ·
$10,853,621,123 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
3,010,000 | $1,784,869,800 | 16.44% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
5,062,500 | $1,157,945,625 | 10.67% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
1,818,181 | $951,763,208 | 8.77% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
22,860,910 | $908,035,344 | 8.37% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
2,888,888 | $746,257,548 | 6.88% | |
| ARGX |
Argenx SE
Healthcare
|
1,000,000 | $730,250,000 | 6.73% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
10,699,999 | $670,889,937 | 6.18% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
7,474,747 | $622,571,677 | 5.74% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
12,222,222 | $491,699,991 | 4.53% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,575,000 | $408,050,500 | 3.76% |
Portfolio Trend
25 quarters · across all stocks
Holdings in KYMR
Shares Held
Position Value (USD)
20 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $622,571,677 | 7,474,747 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $581,610,064 | 7,474,747 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $359,410,000 | 6,350,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $286,084,420 | 6,555,555 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $176,810,200 | 6,460,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $207,184,500 | 5,150,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $212,985,000 | 4,500,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $116,083,306 | 3,888,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $156,333,297 | 3,888,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $96,111,500 | 3,775,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,584,500 | 3,855,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $88,626,450 | 3,855,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $114,223,650 | 3,855,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $96,096,000 | 3,850,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,224,137 | 2,169,230 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,809,400 | 1,260,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,554,280 | 816,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,919,500 | 550,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,770,755 | 455,750 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $1,596,114 | 49,400 | Shares | Sole | 2020-11-16 | |
| No 13F history on record for this holder in this stock. | ||||||